Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Updated on: March 25,2024

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Updated on:March 25,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on: February 20,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on:February 20,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on: January 29,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on:January 29,2024

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on: August 27,2024

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on:August 27,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on: April 28,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on:April 28,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on: February 23,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on:February 23,2024

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on: January 12,2024

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on:January 12,2024

Premature death of autistic people in the UK investigated for the first time

by University College LondonCredit: Unsplash/CC0 Public DomainA new study led by University College London researchers confirms that autistic people experience a reduced life expectancy; however,

Updated on: May 11,2024

Premature death of autistic people in the UK investigated for the first time

by University College LondonCredit: Unsplash/CC0 Public DomainA new study led by University College London researchers confirms that autistic people experience a reduced life expectancy; however,

Updated on:May 11,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on: March 30,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on:March 30,2024

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on: March 30,2024

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on:March 30,2024

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo

Updated on: June 04,2024

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo

Updated on:June 04,2024